Branded Drug Cos. Not Liable For Generics, 5th Circ. Rules
The Fifth Circuit refused Thursday to revive claims by a woman alleging neurological harm from a generic form of heartburn medicine Reglan, saying the U.S. Supreme Court's ruling in Pliva Inc....To view the full article, register now.
Already a subscriber? Click here to view full article